Association between sexual mixing and genital warts in heterosexual men in Australia: the herd protection from the female human papillomavirus vaccination program
Eric P. F. Chow A B C and Christopher K. Fairley A BA Melbourne Sexual Health Centre, Alfred Health, 580 Swanston Street, Carlton, Vic. 3053, Australia.
B Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, 89 Commercial Road, Melbourne, Vic. 3004, Australia.
C Corresponding author. Email: Echow@mshc.org.au
Sexual Health 13(5) 489-490 https://doi.org/10.1071/SH16053
Submitted: 31 March 2016 Accepted: 9 June 2016 Published: 29 July 2016
Abstract
Australian-born women aged ≤32 years were eligible for the free female human papillomavirus (HPV) vaccination program introduced in 2007. A total of 1165 heterosexual couples attending the Melbourne Sexual Health Centre between 2011 and 2014 were included in this analysis. Findings showed the odds of having penile warts was 0.52-fold lower among men who had a female partner aged ≤32 years compared with men who had a female partners aged >32 years. This suggests men would have received herd protection from their female partners and hence they are at lower risk of acquiring genital warts.
References
[1] Barbaro B, Brotherton JM. Assessing HPV vaccine coverage in Australia by geography and socioeconomic status: are we protecting those most at risk? Aust N Z J Public Health 2014; 38 419–23.| Assessing HPV vaccine coverage in Australia by geography and socioeconomic status: are we protecting those most at risk?Crossref | GoogleScholarGoogle Scholar | 24962721PubMed |
[2] Chow EP, Danielewski JA, Fehler G, Tabrizi SN, Law MG, Bradshaw CS, Garland SM, Chen MY, Fairley CK. Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study. Lancet Infect Dis 2015; 15 1314–23.
| Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study.Crossref | GoogleScholarGoogle Scholar | 26201300PubMed |
[3] Tabrizi SN, Brotherton JM, Kaldor JM, Skinner SR, Cummins E, Liu B, Bateson D, McNamee K, Garefalakis M, Garland SM. Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis 2012; 206 1645–51.
| Fall in human papillomavirus prevalence following a national vaccination program.Crossref | GoogleScholarGoogle Scholar | 23087430PubMed |
[4] Chow EP, Read TR, Wigan R, Donovan B, Chen MY, Bradshaw CS, Fairley CK. Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme. Sex Transm Infect 2015; 91 214–9.
| Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme.Crossref | GoogleScholarGoogle Scholar | 25305210PubMed |
[5] Ali H, Donovan B, Wand H, Read TR, Regan DG, Grulich AE, Fairley CK, Guy RJ. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ 2013; 346 f2032
| Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.Crossref | GoogleScholarGoogle Scholar | 23599298PubMed |
[6] Chow EP, Fairley CK. Assortative sexual mixing among heterosexual population in Australia: implications for herd protection in males from the female human papillomavirus vaccination programme. Sex Health 2016; In press.
| Assortative sexual mixing among heterosexual population in Australia: implications for herd protection in males from the female human papillomavirus vaccination programme.Crossref | GoogleScholarGoogle Scholar | 27144872PubMed |
[7] Chow EP, Machalek DA, Tabrizi SN, Dainelewski JA, Fehler G, Bradshaw CS, Garland SM, Chen MY, Fairley CK. Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study. Lancet Infect Dis 2016;
| Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study.Crossref | GoogleScholarGoogle Scholar | 27282422PubMed |
[8] Chow EP, Fairley CK. A second peak in genital warts in later life suggests that behavioural factors explain a second peak in human papillomavirus prevalence in older women. Sex Health 2015; 12 277–8.
| A second peak in genital warts in later life suggests that behavioural factors explain a second peak in human papillomavirus prevalence in older women.Crossref | GoogleScholarGoogle Scholar |
